NCT01568190View on ClinicalTrials.gov

An Open Trial to Assess the Tolerability of AVANZ Mite Mix Immunotherapy

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Allergic Rhinitis Due to Dust Mite
Interventions
BIOLOGICAL

AVANZ MITE

Immunotherapy Dermatophagoides mix

Trial Locations (1)

31008

Hospital Virgen Del Camino, Pamplona

All Listed Sponsors
lead

ALK-Abelló A/S

INDUSTRY

NCT01568190 - An Open Trial to Assess the Tolerability of AVANZ Mite Mix Immunotherapy | Biotech Hunter | Biotech Hunter